Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11-Reference-Cited by-同舟云学术

Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11

Published:2016-09-01 Issue:9 Volume:152 Page:1015
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Funk Tracy¹,Lim Young²,Kulungowski Ann M.³,Prok Lori⁴,Crombleholme Timothy M.³,Choate Keith²,Bruckner Anna L.⁵

Affiliation:

1. Department of Dermatology, Oregon Health & Science University, Portland

2. Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut3Department of Genetics, Yale University School of Medicine, New Haven, Connecticut4Department of Pathology, Yale University School of Medicine, New Haven, Connecticut

3. Division of Pediatric General, Thoracic, and Fetal Surgery, Department of Surgery, University of Colorado School of Medicine, Aurora

4. Department of Dermatology, University of Colorado School of Medicine, Aurora7Department of Pathology, University of Colorado School of Medicine, Aurora

5. Department of Dermatology, University of Colorado School of Medicine, Aurora8Department of Pediatrics, University of Colorado School of Medicine, Aurora

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemangiomas y otros tumores vasculares;EMC - Dermatología;2024-06

2. Capillary malformations;Journal of Clinical Investigation;2024-04-15

3. Benign and low-grade superficial endothelial cell neoplasms in the molecular era;Seminars in Diagnostic Pathology;2023-07

4. Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation;Journal of Biological Engineering;2023-04-27

5. MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ;Nature Communications;2023-04-06